NFE2L2 and amyotrophic lateral sclerosis: Notably, NRF2 is also a major inducer of HMOX1 [29], and the activation of the NRF2/HMOX1 pathway exerts neuroprotection in ALS in vivo models, where the pathway is fully functional [123], supporting the bilirubin-mediated protection in ALS.